Glucose metabolism pathway enzymes

Glucose metabolism pathway enzymes are a collective group of biocatalysts that regulate the flux of glucose through essential metabolic routes, including glycolysis, gluconeogenesis, and the pentose phosphate pathway. These enzymes, such as hexokinase, phosphofructokinase, and pyruvate kinase, are critical for generating adenosine triphosphate (ATP) and providing carbon skeletons for the synthesis of amino acids, lipids, and nucleotides (StatPearls, 2023). In oncology, many of these enzymes are overexpressed to facilitate the Warburg effect, allowing cancer cells to thrive in hypoxic environments and support rapid biomass accumulation (Nature Reviews Cancer, 2011). Conversely, in metabolic diseases like type 2 diabetes, dysregulation of hepatic gluconeogenic enzymes contributes to chronic hyperglycemia (NIH, 2022). Pharmacological targeting of these enzymes aims to either inhibit the metabolic advantages of malignant cells or restore glucose homeostasis in metabolic disorders. For example, hexokinase inhibitors are investigated for their ability to sensitize tumors to chemotherapy, while activators of pyruvate kinase are used to treat hemolytic anemias (PubChem, 2024). However, therapeutic development faces significant challenges regarding systemic toxicity and the preservation of normal cellular energetics in glucose-dependent tissues like the brain.

Other names

Glycolytic enzymesGluconeogenic enzymesCarbohydrate metabolism enzymes

Inhibition of rate-limiting enzymes to modulate metabolic flux, competitive inhibition of substrate binding, and allosteric regulation of enzymatic activity.